chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she had a little problem; This spontaneous case was reported by a patient family member or friend and describes the occurrence of IMMUNISATION REACTION (she had a little problem) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (she had a little problem). At the time of the report, IMMUNISATION REACTION (she had a little problem) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Patient's sister reported that on an unknown date, patient received Moderna COVID-19 vaccine and had a little problem.  Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
got very sick from Flu; Initial information received on 21-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and gender patient who got very sick from Flu after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a 1 DF (Dosage Form) dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, strength, formulation, expiry date was not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed got very sick from Flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if there were lab data/results available.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
I thought it was sinus (runny nose and throat irritation) while traveling so I didn't think much pf it. On 06/12/2022 and 06/15/2022 I tested myself with an at home COVID-19 test and they were both positive. On 06/13/2022 I called my primary doctor and I told him I tested positive and he prescribed PAXLOVID. I started my medication and I started to feel a little better so I drove to my home state. I got home on 06/19/2022 and the medication was completely finish. I final tested negative June 25,2022. I tested again on the next day which was also negative. On July 2,8th and 17th  these were all negative test. I felt the need to test was because of the sinus issues I was having and I wanted to make sure I didn't get re-infected.
few days after vaccine, ankles hurt and began to swell/ leg area below knees felt stiff and began to swell and turn red/still swollen but redness subsiding PATIENT TO CALL HER DOCTOR 11/15/20 AM
The patient was brought to the ED on 10/22 by EMS for weakness and nausea, and upon EMS arrival the patient was on the bathroom floor. The patient reports she went to use the bathroom and fell over and couldn't stand up because she felt weak. She also reported flank pain, fever, and chills. She had a temperature of 101.7 F. In the ED, the patient reported pain to her neck, back, side, abdomen, and legs. COVID-19 PCR testing was done on 10/22 which was positive. The patient was admitted to the hospital on 10/22-10/23. She did not require supplemental O2. She has received two doses of the COVID vaccine.
In August 2022, I was traveling in another state when I came down with COVID-19. I was unable to get to get treatment from any healthcare as it is pretty desolate in places. I was very sick; my husband and I slept in the car trying to make our way back home. Once I got home, I started to experience chronic diarrhea that lasted for a month, I had fatigue and a cough. I went to the doctor, I was given stool kits, but I was unable to get the stool kits in. The diarrhea finally subsided, I then started experiencing heart rate spikes. It started to happen occasionally, then started to happen more often. Then two days consecutively my heart rate stayed elevated. My husband took me to urgent care, I was there for 10 minutes, and they took the emergency room. I had an EKG, echocardiogram, ultrasound. Everything came back normal. I was told to check back with my cardiologist. I did follow up with my cardiologist who had me wear a Holter monitor he told me to go to my endocrinologist and have my thyroid checked out again. I have not followed up with my endocrinologist yet.
I have been discharged from the hospital with pericarditis; Went into walk in on 10May, and was rushed to ER due to heart issue. ER states I possibly had a heart attack; The Sunday following 2nd dose, woke up with severe chest pains; This is a spontaneous report from a contactable consumer (patient). A 24-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 06May2021 18:30 (Lot Number: ew0171) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history was none. The patient was healthy. No other vaccine in four weeks. No covid prior vaccination. Concomitant medication(s) included ibuprofen. The patient took the first dose of bnt162b2 on 15Apr2021 07:00 PM (Lot number EW0153) in left arm for COVID-19 immunisation. On 09May2021 03:30 AM, the patient woke up with severe chest pains. Went into walk in on 10May, and was rushed to ER due to heart issue. ER stated he possibly had a heart attack, and now he had been discharged from the hospital with pericarditis. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient hospitalized for two days. Multiple treatments administered. The patient had covid test type post vaccination nasal swab on 10May2021 with negative result. The outcome was unknown.
pt recv vax & 3 days /vax pt paralyzed both lower extremities;loss of sphincter tone;
about 20 minutes later, cheeks felt flushed and turned bright red, slight itching around the face and upper body
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (04Sep2022) Positive, notes: I tested positive for covid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: COVID 19 Treated with Paxlovid started on 28Aug2022, stopped on 01Sep2022. The patient tested positive for covid again and then started having symptoms three days after stopping paxlovid. Event started on: 04Sep2022, Recovering.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
15 month old female Received MMR and DTap Vaccine at well check up visit on 06/06/18. The pediatrican stated that she had a red ear at time of visit and suspected she may have an ear infection which she later prescribed amoxicillin for on 06/09/18. After being on antibiotics for 6 days she then spiked high fevers 104 degrees and higher (nine days after receiving vaccine). The 15 month old was then brought to pediatrician's office and was examined. Pediatrician stated that she believed it was roseola and suspected a rash would appear after the fevers broke. Fever broke on Sunday June 17 and the 15 month old began a rash that spread to her whole body including her trunk, torso, ears, soles of feet and palms of hands. The 15 month old was then brought back to pediatrician as the rash did not look like roseola pediatrician stated that she agreed that rash did not present at roseola and instead looked like measles that may have been caused by the live vaccine in which she received.
Patient developed severe mucositis found to have adenovirus infection. Dermatology consulted and felt that this may have been an immune response in setting of recent infection given that he had the vaccine on 12/30 and developed symptoms on 1/2
Case number PHEH2016US025546 is an initial incomplete spontaneous report received from a pharmacist on 30 Sep 2016. This report refers to multiple patients whose identifiers were not reported. Past medical history and concomitant medications were not reported. These patients were vaccinated with FLUVIRIN (batch number: 169303, 168601) prefilled syringe (PFS) at a dose of 0.5 ml intramuscularly on 30 Sep 2016. It was reported that the FLUVIRIN PFS was left at room temperature for 4 hours during flu clinic and an unspecified number of patients were administered this vaccine. The case was reported as non-serious. No adverse events were reported following the inadvertent administration. Follow up information was received on 24 Oct 2016 from a pharmacist. The pharmacist reported that there were no vaccine left out at room temperature and the patients never received these vaccines. It was just an inquiry. Hence this case is deactivated.
Information has been received from a certified medical assistant concerning a 67 year old male patient who on 04-MAY-2010 was vaccinated subcutaneously into his left arm with a dose of PNEUMOVAX 23 (lot# 662268/1134Y) that had expired on 11-APR-2010. No adverse effects were reported. The patient did not seek medical attention. Follow-up information has been received from a doctor concerning a 67 year old patient who on 04-MAY-2010 was vaccinated with the first dose of PNEUMOVAX 23 into his left deltoid. On 05-MAY-2010, the patient stated he had about softball size redness, hardness and warm feeling at the site of the injection for 2 weeks. No further information is available.
Red, swollen, hot to touch. Tylenol 5ml PO now. Bactrim 400 80mg tabs 2 tsp PO BID start 7/11/07 Benadryl.
Information has been received from a medical assistant concerning a 47 year old female patient, who "3 weeks ago", in approximately 25-AUG-2009 was vaccinated with a dose of PNEUMOVAX 23 (dose, route and product lot unspecified). There was no concomitant medication, pertinent medical history and drug reactions/allergies. The patient developed hives, shortness of breath, soreness at the injection site, redness at the injection site and headaches after receiving PNEUMOVAX 23. The patient also complained of being confused and tired. At the time of the report the patient was recovering. The patient sought unspecified medical attention. No laboratory diagnostics studies were performed. Follow-up information has been received from a physician. It was reported that the patient was diagnosed with bed bugs. Per the patient's allergist, these adverse events were not a reaction to the vaccine. No further information is available.
58 y/o female with past medical history of Hypertension who presents with left arm numbness post vaccination. Patient states that this is her first vaccination in the two-dose series. Patient denies previous reactions to vaccinations in the past. Patient states that she received the vaccination to the Left arm. Patient states that her left arm feels numbness or like it has fallen asleep. NP and Paramedics at patient side. Patient with equal pulses to bilateral upper extremities, cap refill less than 3 seconds, patient with FROM of the left upper extremity. Patient denies sore throat, difficulty swallowing, difficulty breathing and/or chest pain. Instructed patient to move/exercise the left upper extremity. Patient with Hypertension on initial vitals, 173/104 BP, 98% RA, 78 HR, 12 Resp, EKG NSR. Patient states that she took both of her blood pressure medications this am (Losartan and Hydrochlorothiazide). Within 30 mins patient with resolution of left arm numbness but hypertension remained. BP taken siting, lying, standing with no improvement. Patient BP increased to 182/107 and Rescue notified. Fire rescue was delayed in arriving. Patient was monitored by NP and Paramedics for over an hour. Once rescue arrived patient BP normalized to 150/99. Patient refused transport to ER. Patient signed AMA with rescue and patient was provided with the AMA form, patient signed and ambulated off site without difficulty.
One week following her inital vaccine she noticed the injection site was red swollen and hot. the area was itchy and was surrounded by a rash.
Fever, chills, headache, difficulty hearing  starting the night of the shot and so far the next day as well.  Given Tylenol every 6 hours.
This non-serious initial spontaneous case, was received from other health professional (nurse) on 30-Oct-2017, concerning a 63-year-old female patient. The patient had no medical history and she did not receive any concomitant vaccine. On 30-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (batch number; XF35109, expiry date: 30-Jun-2018, dose, route of administration: topical to skin, anatomical location: not reported). The nurse went to administer the vaccine to the patient and did not have needle on syringe and the entire dose went down the patient's arm and no adverse reactions had occurred. The arm was immediately washed off with soap and water and she had not any problems. The nurse also stated that the patient did not actually receive the vaccine, the contact of the syringe when plunger pushed went all over the top of skin but did not penetrate skin. Follow up received from nurse on 22-Nov-2017: added reporter's comment.
Have felt nauseous; Had horrible headaches; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Nov2021 12:00 (Batch/Lot number: unknown) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Gluten-celiac disease allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 04Nov2021, outcome "not recovered", described as "Have felt nauseous"; HEADACHE (non-serious) with onset 04Nov2021, outcome "not recovered", described as "Had horrible headaches". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of nausea, headache.  Additional information: The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient had not been diagnosed with COVID-19.Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
URINARY TRACT INFECTION; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the subject experienced urinary tract infection. The action taken with covid-19 vaccine was not applicable. The outcome of urinary tract infection was not reported. This report was non-serious. This case, from the same reporter is linked to 20210605720.
I experienced an intense inflammatory response in left hip, leg, foot down to big toe with a dropped foot.  I had to have ultrasound of leg in ER for intense pain to rule out a blood clot.  Doctor ordered Physical Therapy and I was in PT for over 3 months and no one is sure why I had this neural issue that began  7 days after the second shot.
Left upper arm swelling with erythema.  Diameter approximately 10cm.  Prescribed: Benadryl.
Felt dizzy; Throw up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt dizzy) and VOMITING (Throw up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DIZZINESS (Felt dizzy) and VOMITING (Throw up). At the time of the report, DIZZINESS (Felt dizzy) and VOMITING (Throw up) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 08-Jun-2021, the patient reported, she was doing fine and did not need anything anymore.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow up received on 16-Apr-2021 did not contain any new information. On 08-Jun-2021: Outcome of events updated.
Starting day 3- Headache, neck, dizziness  Day 5- same as above but started fever in evenings  Day 7- same as above but getting worse minus fever End of  2 week - getting worse went to med express because my bp went to 200/113 they sent me to ER where I was getting treated for bp and vertigo. Started having severe muscle spasms at night  Got blood work taken a week later and change bp medication to try and get in under control  Blood work came back great, no family history of high blood pressure, bp still not where it needs to be so had to upper medicine go back in 2 weeks for re check. All of this happened right after vaccine and it has been awful.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021 at 1:30 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Nov-2021 at 1:30 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication information was provided. Excursion duration was 1 month reported by reporter.   This case was linked to MOD-2021-402935 (Patient Link).
Moderna COVID-19 Vaccine EUA: unable to lift my right arm above head. swelling and stiff muscle near injection site. muscle pain in areas near injection site (shoulder, upper back, chest, arm)
devel a 4inch x 2inch itchy, hard, red wheal @ site of the inj-varied between locally sore & locally very itchy till today 23OCt97;pt has recv vax other yr including last year w/rxn;reporter states 5/8" needle went SC not IM;
Pt. states approximately 5 hrs. after receiving MMR yesterday she noticed that her gums were sensitive.  When she awakened the next AM her upper lip was noticeably swollen "and tight".  Her gums were also swollen.  She was able to eat breakfast and drink fluids without difficulty.  Denies that she had any difficulty swallowing or breathing at any time.  When seen in clinic at 3:01 pm she reported that her lips were "normal", her gums were still "slightly swollen" (not noticeable on PE) and she had detected a bump behind one of her front teeth  (again not noticeable on PE).  She also denies any other s/s of an allergic reaction, ie tight chest, wheezing, hives, etc.  The only medicine she's taken is Tylenol.  After consult with Dr, pt. advised to return to clinic if symptoms increased or changed.  Advised how to contact the universities after hour nurses for health advice.
I had mild fever and chills after my 2nd dose. March 2022, My blood pressure went sky high, higher than normal. I went to the emergency room and they brought it down and I went home.
Patient is found with secondary provider reporting the patient had an episode of syncope and hypotension. Patient reports that she is hot, diaphoreticand dizzy after receiving J&J Vaccine. A 12 lead ECG is completed as noted in chart. Patient's vitals are taken as noted in chart. Patient reports that she is beginning to feel better, patient continues to be monitored by EMS. Patient is found A&O x4, flushed warm and diaphoretic. Patient has no noted neurological deficits, pupils are PERRL. No trauma is noted to patient's face. Airway is patent, respirations are as noted. No JVD is noted, trachea is midline. Patient has equal chest rise/fall, lung sounds are equal bi-laterally. Patient denies chest pain, shortness of breath. Abdomen is soft/non tender. Patient denies abdominal pain, no GI/GU Symptoms are noted. Patient has no deficits noted to extremities, pulses are strong. Patient denies covid 19 concerns, other injuries or illness. 12 lead ECG is taken showing sinus rhythm as noted in chart
Initial unsolicited report received from a consumer on 06-Jan-2017. This case was non-valid for unspecified adverse event was. This case is linked with: 2017SA004589, 2017SA004593 AND 2017SA004447. This case involves an 88-year-old female patient, who was vaccinated with INFLUENZA VACCINE (FLU VACCINE) (batch number, expiry date, route, dose not reported) on an unknown date. Patient's medical history and concomitant medication was not reported. On an unknown date, after the vaccination, the patient had reaction to a flu vaccine. Lab test and corrective treatment was not reported. Follow up report received from a consumer on 22 FEB 2017 and additional information received on 10 MAR 2017. Illness at the time of vaccination was none. On an unspecified date in OCT 2016 at 09:00 am the patient was vaccinated with INFLUENZA VACCINE (FLU VACCINE). On an unspecified date, following the vaccination the patient experienced muscle pain, rash, neck pain and shoulder pain. It was reported as exam by family doctor. On an unspecified date, at the age of 87 years old the patient received INFLUENZA VACCINE (FLU VACCINE). On an unspecified date (duration reported as 2 months), the patient was recovered from the events. Documents held by sender: none.